NeuroRestore is a research and innovation institution that develops and implements medical remedies to restore neurological functions.
NeuroRestore has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in April 2024.
NeuroRestore's investors include Michael J. Fox Foundation, Reeve Foundation.
NeuroRestore is headquartered in Vaud, Switzerland.
NeuroRestore is a research and innovation institution that develops and implements medical remedies to restore neurological functions.
NeuroRestore is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroRestore — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/neurorestore. Accessed August 14, 2026.
VCBacked. (2024). NeuroRestore — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/neurorestore
{{cite web |title=NeuroRestore — Funding & Investors |url=https://www.vcbacked.co/company/neurorestore |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated